Thyrocare Technologies Limited had earlier announced that the company has appointed Mr. Rahul Guha as the Managing Director & Chief Executive Officer of the company and that he would be joining in the month of May 2022.
Mr. Rahul Guha has taken charge as the Managing Director & Chief Executive Officer with effect from Wednesday, May 04, 2022.
Mr. Rahul Guha will also function as the Managing Director & CEO of Nueclear Healthcare Limited, the wholly owned subsidiary.
Mr. Dhannil Sheth, who was appointed as the Managing Director for the interim period to comply with the provisions of Sec. 203 (4) of the Companies Act, 2013, has demitted office effective from Wednesday, May 04, 2022 and will continue to be a Non-Executive, Non-Independent Director of the Company.